Publications by authors named "Dave Johnson"

Claim this Profile
C
Crowdsourcing multiverse analyses to explore the impact of different data-processing and analysis decisions: A tutorial.
Tom Heyman, Ekaterina Pronizius, Savannah C Lewis, Oguz A Acar, Matúš Adamkovič, Dave C Johnson

Psychol Methods· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Retention in Oxford Houses and Other Types of Recovery Housing: A Scoping Review.
Joseph Ellis, Mira Mirzaian, Eleanor Sudduth, Maddison Ashworth, Robin Thompson, Dave Johnson

Subst Use Misuse· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project.
Jeffrey G Edwards, Adam P Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson

Pediatr Blood Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Technical Assistance Needs among Recovery Residence Operators in the United States.
Jennifer Miles, Terry Bunn, Amber Kizewski, Tyler Jennings, Teresa Waters, Dave Johnson

J Psychoactive Drugs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring Advanced Practice Provider Productivity at the National Comprehensive Cancer Network's Member Institutions.
Diana Krause, Karen Sharrah, Anne Gross, Danielle Bowers, Daniel Mulkerin, Dave Johnson

J Adv Pract Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and in vivo assessment of a novel MRI-compatible headframe system for the ovine animal model.
Marco Trovatelli, Stefano Brizzola, Davide Danilo Zani, Antonella Castellano, Paola Mangili, Dave Johnson

Int J Med Robot· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagus nerve injury symptoms after catheter ablation for atrial fibrillation.
Victoria Jacobs, Heidi T May, Brian G Crandall, Becca Ballantyne, Ben Chisum, Dave Johnson

Pacing Clin Electrophysiol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Return on investment in healthcare leadership development programs.
Maya M Jeyaraman, Sheikh Muhammad Zeeshan Qadar, Aleksandra Wierzbowski, Farnaz Farshidfar, Justin Lys, Dave Johnson

Leadersh Health Serv (Bradf Engl)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empirically derived guidance for social scientists to influence environmental policy.
Nadine Marshall, Neil Adger, Simon Attwood, Katrina Brown, Charles Crissman, Dave Johnson

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measles Outbreak - Minnesota April-May 2017.
Victoria Hall, Emily Banerjee, Cynthia Kenyon, Anna Strain, Jayne Griffith, Dave Johnson

MMWR Morb Mortal Wkly Rep· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma.
Azeem Arshad, Bin Yang, Alison S Bienemann, Neil U Barua, Marcella J Wyatt, Dave E Johnson

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.
John C Byrd, Bonnie Harrington, Susan O'Brien, Jeffrey A Jones, Anna Schuh, Dave Johnson, Amy J Johnson

N Engl J Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.
Jennifer R Brown, John C Byrd, Steven E Coutre, Don M Benson, Ian W Flinn, Dave M Johnson

Blood· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
Richard R Furman, Jeff P Sharman, Steven E Coutre, Bruce D Cheson, John M Pagel, Dave M Johnson

N Engl J Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.
Ajay K Gopal, Brad S Kahl, Sven de Vos, Nina D Wagner-Johnston, Stephen J Schuster, Dave Johnson

N Engl J Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma.
Sarah A Meadows, Francisco Vega, Adam Kashishian, Dave Johnson, Volker Diehl

Blood· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic analysis of phenanthrene degrading Sphingomonas biofilms exposed to environmentally relevant solute and matric stresses.
Tekle Tafese Fida, Philip Breugelmans, Rob Lavigne, Edith Coronado, Dave Johnson

Commun Agric Appl Biol Sci· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation of 14C-trinitrotoluene and related nonextractable (bound) residues in Eisenia fetida.
Jason B Belden, Guillerme R Lotufo, C Kevin Chambliss, Jonathan C Fisher, Dave R Johnson

Environ Pollut· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of local rifampin/minocycline delivery (AIGIS(RX)®) to eliminate biofilm formation on implanted pacing devices in a rabbit model.
Linda K Hansen, Kim Berg, Dave Johnson, Mark Sanders, Mark Citron

Int J Artif Organs· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK1.1+ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model.
Calin D Dumitru, Mary A Antonysamy, Kevin S Gorski, Dave D Johnson, Laxma G Reddy

Cancer Immunol Immunother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug delivery from gold and titanium surfaces using self-assembled monolayers.
Gopinath Mani, Dave M Johnson, Denes Marton, Marc D Feldman, Devang Patel

Biomaterials· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of self-assembled monolayers on titanium and gold.
Gopinath Mani, Dave M Johnson, Denes Marton, Victoria L Dougherty, Marc D Feldman

Langmuir· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug delivery from therapeutic self-assembled monolayers (T-SAMs) on 316L stainless steel.
Anil Mahapatro, Dave M Johnson, Devang N Patel, Marc D Feldman, Arturo A Ayon

Curr Top Med Chem· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug loading of nanoporous TiO2 films.
Arturo A Ayon, Michael Cantu, Kalpana Chava, C Mauli Agrawal, Marc D Feldman, Dave Johnson

Biomed Mater· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of alkanethiol self-assembled monolayers on 316L stainless steel for coronary artery stent nanomedicine applications: an oxidative and in vitro stability study.
Anil Mahapatro, Dave M Johnson, Devang N Patel, Marc D Feldman, Arturo A Ayon

Nanomedicine· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis